Sennosides Tablet
FDA Label NDC 87717-501

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Morepen Bio Inc for the product Sennosides (NDC 87717-501). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, indications and usage, dosage and administration, inactive ingredients, questions or comments, warnings, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.